1. Home
  2. EVOK vs OLB Comparison

EVOK vs OLB Comparison

Compare EVOK & OLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • OLB
  • Stock Information
  • Founded
  • EVOK 2007
  • OLB 1993
  • Country
  • EVOK United States
  • OLB United States
  • Employees
  • EVOK N/A
  • OLB N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • OLB EDP Services
  • Sector
  • EVOK Health Care
  • OLB Technology
  • Exchange
  • EVOK Nasdaq
  • OLB Nasdaq
  • Market Cap
  • EVOK 5.4M
  • OLB 4.4M
  • IPO Year
  • EVOK 2013
  • OLB N/A
  • Fundamental
  • Price
  • EVOK $5.12
  • OLB $1.36
  • Analyst Decision
  • EVOK
  • OLB
  • Analyst Count
  • EVOK 0
  • OLB 0
  • Target Price
  • EVOK N/A
  • OLB N/A
  • AVG Volume (30 Days)
  • EVOK 432.5K
  • OLB 92.0K
  • Earning Date
  • EVOK 11-06-2025
  • OLB 11-14-2025
  • Dividend Yield
  • EVOK N/A
  • OLB N/A
  • EPS Growth
  • EVOK N/A
  • OLB N/A
  • EPS
  • EVOK N/A
  • OLB N/A
  • Revenue
  • EVOK $12,794,859.00
  • OLB $10,410,379.00
  • Revenue This Year
  • EVOK $57.38
  • OLB N/A
  • Revenue Next Year
  • EVOK $59.57
  • OLB N/A
  • P/E Ratio
  • EVOK N/A
  • OLB N/A
  • Revenue Growth
  • EVOK 70.02
  • OLB N/A
  • 52 Week Low
  • EVOK $1.94
  • OLB $0.95
  • 52 Week High
  • EVOK $12.32
  • OLB $3.27
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 49.82
  • OLB 56.62
  • Support Level
  • EVOK $5.00
  • OLB $1.21
  • Resistance Level
  • EVOK $5.27
  • OLB $1.38
  • Average True Range (ATR)
  • EVOK 0.22
  • OLB 0.11
  • MACD
  • EVOK -0.05
  • OLB 0.04
  • Stochastic Oscillator
  • EVOK 38.91
  • OLB 90.05

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About OLB The OLB Group Inc.

The OLB Group Inc is a diversified fintech e-commerce merchant services provider and Bitcoin crypto mining enterprise. It focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. Along with its subsidiaries, the company offers a cloud-based business management platform that provides turnkey solutions for merchants to enable them to build and manage their retail businesses, whether online or at a brick-and-mortar location, payment processing solutions, payment gateway, virtual terminal with proprietary business management tools, and crowdfunding solutions. The company has two business segments; Fintech Services which generates key revenue, and the Bitcoin Mining business segment.

Share on Social Networks: